Detalles de la búsqueda
1.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
N Engl J Med
; 390(4): 326-337, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38078508
2.
Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial.
Blood
; 141(14): 1666-1674, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564045
3.
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 535-552, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142374
4.
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Br J Haematol
; 201(2): 267-279, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36541152
5.
Personalizing neoadjuvant chemotherapy for locally advanced colon cancer: protocols for the international phase III FOxTROT2 and FOxTROT3 randomized controlled trials.
Colorectal Dis
; 25(3): 357-366, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710525
6.
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials.
Blood
; 136(9): 1091-1104, 2020 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438407
7.
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
PLoS Med
; 18(1): e1003454, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428632
8.
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial.
Br J Haematol
; 192(5): 853-868, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656799
9.
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.
Haematologica
; 106(7): 1957-1967, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32499244
10.
Subclonal TP53 copy number is associated with prognosis in multiple myeloma.
Blood
; 132(23): 2465-2469, 2018 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373884
11.
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.
J Pathol
; 247(3): 381-391, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30426503
12.
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(1): 57-73, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30559051
13.
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Br J Haematol
; 185(3): 450-467, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30729512
14.
Redefining nonmeasurable multiple myeloma using mass spectrometry.
Blood
; 139(6): 946-950, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871382
15.
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients.
Haematologica
; 104(7): 1440-1450, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30733268
16.
Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study.
Br J Haematol
; 182(6): 816-829, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984830
17.
Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests.
Br J Haematol
; 178(2): 220-230, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573706
18.
Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial.
Biol Blood Marrow Transplant
; 22(6): 1009-1016, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26827659
19.
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients.
Haematologica
; 106(10): 2754-2758, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092058
20.
Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial.
JAMA
; 316(10): 1051-60, 2016 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27570866